4893 items matching your search terms.

Anaphylaxis fatalities in Australia 1997 to 2013

Campbell, D. Wainstein, B. Liew, W. K. Barnes, E. Mullins, R. J.

Time to definitive failure to the first tyrosine kinase inhibitor in localized GI stromal tumors treated with imatinib as an adjuvant: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group intergroup randomized trial in collaboration with the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas

Casali, Paolo G. Le Cesne, Axel Poveda Velasco, Andres Kotasek, Dusan Rutkowski, Piotr Hohenberger, Peter Fumagalli, Elena Judson, Ian R. Italiano, Antoine Gelderblom, Hans Adenis, Antoine Hartmann, Jörg T. Duffaud, Florence Goldstein, David Broto, Javier M. Gronchi, Alessandro Dei Tos, Angelo P. Marréaud, Sandrine van der Graaf, Winette T.A. Zalcberg, John R. Litière, Saskia Blay, Jean-Yves
JOURNAL OF CLINICAL ONCOLOGY, 2015     DOI:10.1200/jco.2015.62.4304

Antiangiogenic agents in metastatic oesophago-gastric cancer: a systematic review and meta-analysis

Chan, D. Goldstein, D. Sjoquist, K.M. Pavlakis, N.

Does the chemotherapy backbone impact on the efficacy of targeted agents in metastatic colorectal cancer? A systematic review and meta-analysis of the literature [correction 10(9):e0138916]

Chan, D. L. Pavlakis, N. Shapiro, J. Price, T. J. Karapetis, C. S. Tebbutt, N. C. Segelov, E.
PLOS ONE, 2015     DOI:10.1371/journal.pone.0135599

Clinical utility of ramucirumab in advanced gastric cancer

Chan, M. M. Sjoquist, K. M. Zalcberg, J. R.
BIOLOGICS, 2015     DOI:10.2147/btt.s62777

Meta-analysis of radical resection rates and margin assessment in pancreatic cancer

Chandrasegaram, M. D. Goldstein, D. Simes, J. Gebski, V. Kench, J. G. Gill, A. J. Samra, J. S. Merrett, N. D. Richardson, A. J. Barbour, A. P.
BRITISH JOURNAL OF SURGERY, 2015     DOI:10.1002/bjs.9892

Precision medicine for advanced pancreas cancer: the Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) trial

Chantrill, L.A. Nagrial, A.M. Watson, C. Johns, A. L. Martyn-Smith, M. Simpson, S. Mead, S. Jones, M.D. Samra, J.S. Gill, A.J. Watson, N. Chin, V.T. Humphris, J.L. Chou, A. Brown, B. Morey, A. Pajic, M. Grimmond, S.M. Chang, D.K. Thomas, D. Sebastian, L. Sjoquist, K. Yip, S. Pavlakis, N. Asghari, R. Harvey, S. Grimison, P. Simes, J. Biankin, A. V.
CLINICAL CANCER RESEARCH, 2015     DOI:10.1158/1078-0432.ccr-15-0426

A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention

Chen, A. C. Martin, A. J. Choy, B. Fernandez-Penas, P. Dalziell, R. A. McKenzie, C. A. Scolyer, R. A. Dhillon, H. M. Vardy, J. L. Kricker, A. St George, G. Chinniah, N. Halliday, G. M. Damian, D. L.
NEW ENGLAND JOURNAL OF MEDICINE, 2015     DOI:10.1056/NEJMoa1506197

Effects of fenofibrate on hypoxia tolerance in diabetes and associated molecular mechanisms

Chen, S. King, E. Yuan, J. Jenkins, A. Keech, A. Ng, M.
, 2015     DOI:10.1016/j.hlc.2015.06.016

Weighing up the benefits and harms of a new anti-cancer drug: a survey of Australian oncologists

Chim, L. Salkeld, G. Stockler, M. R. Mileshkin, L.
INTERNAL MEDICINE JOURNAL, 2015     DOI:10.1111/imj.12802

Is it time to repair a fairly fast SAAB convertible? Testing an evidence-based mnemonic for the secondary prevention of cardiovascular disease

Chin, J. Fulcher, J. Jenkins, A. Keech, A.
HEART, LUNG & CIRCULATION, 2015     DOI:10.1016/j.hlc.2014.11.016

Targeted therapies in the treatment of advanced pancreatic adenocarcinoma: a systematic review and meta-analysis of randomized trials

Chin, VT Nagrial, A Chantrill, LA Sjoquist, KM O'Connor, C Pajic, M Biankin, AV Yip, D

Protein disulfide isomerase in thrombosis

Chiu, J. Passam, F. Butera, D. Hogg, P. J.
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2015     DOI:10.1055/s-0035-1564047

How effective are novel biological therapies? A systematic review of 121 randomized controlled trials

Cho, D. Roncolato, F. Man, J.J. Lord, S.J. Links, M. Simes, J. Lee, C.K.

Red clover isoflavones enriched with formononetin lower serum LDL cholesterol-a randomized, double-blind, placebo-controlled study

Clifton-Bligh, P. B. Nery, M. L. Clifton-Bligh, R. J. Visvalingam, S. Fulcher, G. R. Byth, K. Baber, R.
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2015     DOI:10.1038/ejcn.2014.207